Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus.

The gut mycobiota (fungal microbiota) plays a crucial role in the immune system, potentially impacting autoimmune diseases such as systemic lupus erythematosus (SLE). Despite growing interest, data on intestinal fungi in SLE remain limited. This study thereby investigated the human-mimicked (mice) g...

Full description

Saved in:
Bibliographic Details
Main Authors: Thanya Cheibchalard, Asada Leelahavanichkul, Piraya Chatthanathon, Piriya Klankeo, Nattiya Hirankarn, Naraporn Somboonna
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0314662&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846129367016538112
author Thanya Cheibchalard
Asada Leelahavanichkul
Piraya Chatthanathon
Piriya Klankeo
Nattiya Hirankarn
Naraporn Somboonna
author_facet Thanya Cheibchalard
Asada Leelahavanichkul
Piraya Chatthanathon
Piriya Klankeo
Nattiya Hirankarn
Naraporn Somboonna
author_sort Thanya Cheibchalard
collection DOAJ
description The gut mycobiota (fungal microbiota) plays a crucial role in the immune system, potentially impacting autoimmune diseases such as systemic lupus erythematosus (SLE). Despite growing interest, data on intestinal fungi in SLE remain limited. This study thereby investigated the human-mimicked (mice) gut mycobiome and quantitative gut mycobiome analyses using universal fungal internal transcribed spacer 2 (ITS2) DNA next generation sequencing and real-time PCR, tracking time-series dynamics from preclinical to established SLE conditions in two SLE-prone mouse models. These models included pristane -induced mice, representing an environmental cause of SLE, and Fc gamma receptor RIIb (FcgRIIb) deficiency mice, representing a genetic factor. Fecal samples and different intestinal sections from mice aged 2-10 months were analyzed, including samples from 4-month-old and 11-month-old mice, which represented preclinical lupus (negative for anti-dsDNA) and established SLE conditions (positive for anti-dsDNA with proteinuria), respectively, alongside age-matched healthy controls. Results showed increased fungal diversity, specific changes in gut fungal species (i.e. increased Candida spp.), and an elevated Basidiomycota-to-Ascomycota (Basidiomycota/Ascomycota) ratio, which correlated with lupus activity in both lupus models. Linear discriminant analysis Effect Size (LEfSe; a possible representative organism) helped identify specific fungal difference between the lupus models. Our findings revealed that active lupus states may elevate gut fungal populations and alter fungal components in both the pristane and genetically susceptible SLE-prone mice, as indicated by mycobiota and quantitative mycobiota analyses. These changes could, in turn, influence disease activity. This research is essential for a deeper understand of the SLE-gut microbiome association, as the gut microbiome comprises both bacterial and fungal symbiosis. Manipulating fungal communities could present a potential therapeutic avenue for influencing disease outcomes in lupus. Further studies are crucial to clarify the direct role of gut fungi in lupus disease progression.
format Article
id doaj-art-0fa5f75e4f9e4b5cadb5e474366beca8
institution Kabale University
issn 1932-6203
language English
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-0fa5f75e4f9e4b5cadb5e474366beca82024-12-10T05:32:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011912e031466210.1371/journal.pone.0314662Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus.Thanya CheibchalardAsada LeelahavanichkulPiraya ChatthanathonPiriya KlankeoNattiya HirankarnNaraporn SomboonnaThe gut mycobiota (fungal microbiota) plays a crucial role in the immune system, potentially impacting autoimmune diseases such as systemic lupus erythematosus (SLE). Despite growing interest, data on intestinal fungi in SLE remain limited. This study thereby investigated the human-mimicked (mice) gut mycobiome and quantitative gut mycobiome analyses using universal fungal internal transcribed spacer 2 (ITS2) DNA next generation sequencing and real-time PCR, tracking time-series dynamics from preclinical to established SLE conditions in two SLE-prone mouse models. These models included pristane -induced mice, representing an environmental cause of SLE, and Fc gamma receptor RIIb (FcgRIIb) deficiency mice, representing a genetic factor. Fecal samples and different intestinal sections from mice aged 2-10 months were analyzed, including samples from 4-month-old and 11-month-old mice, which represented preclinical lupus (negative for anti-dsDNA) and established SLE conditions (positive for anti-dsDNA with proteinuria), respectively, alongside age-matched healthy controls. Results showed increased fungal diversity, specific changes in gut fungal species (i.e. increased Candida spp.), and an elevated Basidiomycota-to-Ascomycota (Basidiomycota/Ascomycota) ratio, which correlated with lupus activity in both lupus models. Linear discriminant analysis Effect Size (LEfSe; a possible representative organism) helped identify specific fungal difference between the lupus models. Our findings revealed that active lupus states may elevate gut fungal populations and alter fungal components in both the pristane and genetically susceptible SLE-prone mice, as indicated by mycobiota and quantitative mycobiota analyses. These changes could, in turn, influence disease activity. This research is essential for a deeper understand of the SLE-gut microbiome association, as the gut microbiome comprises both bacterial and fungal symbiosis. Manipulating fungal communities could present a potential therapeutic avenue for influencing disease outcomes in lupus. Further studies are crucial to clarify the direct role of gut fungi in lupus disease progression.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0314662&type=printable
spellingShingle Thanya Cheibchalard
Asada Leelahavanichkul
Piraya Chatthanathon
Piriya Klankeo
Nattiya Hirankarn
Naraporn Somboonna
Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus.
PLoS ONE
title Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus.
title_full Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus.
title_fullStr Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus.
title_full_unstemmed Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus.
title_short Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus.
title_sort fungal microbiome in gut of systemic lupus erythematosus sle prone mice pristane and fcgriib deficiency a possible impact of fungi in lupus
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0314662&type=printable
work_keys_str_mv AT thanyacheibchalard fungalmicrobiomeingutofsystemiclupuserythematosusslepronemicepristaneandfcgriibdeficiencyapossibleimpactoffungiinlupus
AT asadaleelahavanichkul fungalmicrobiomeingutofsystemiclupuserythematosusslepronemicepristaneandfcgriibdeficiencyapossibleimpactoffungiinlupus
AT pirayachatthanathon fungalmicrobiomeingutofsystemiclupuserythematosusslepronemicepristaneandfcgriibdeficiencyapossibleimpactoffungiinlupus
AT piriyaklankeo fungalmicrobiomeingutofsystemiclupuserythematosusslepronemicepristaneandfcgriibdeficiencyapossibleimpactoffungiinlupus
AT nattiyahirankarn fungalmicrobiomeingutofsystemiclupuserythematosusslepronemicepristaneandfcgriibdeficiencyapossibleimpactoffungiinlupus
AT narapornsomboonna fungalmicrobiomeingutofsystemiclupuserythematosusslepronemicepristaneandfcgriibdeficiencyapossibleimpactoffungiinlupus